Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 3/4/2020
SIETES contiene 92955 citas

 1 a 20 de 20 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Healy D, Mangin D. Clinical judgments, not algorithms, are key to patient safety. BMJ 2019;367:2 de octubre. [Ref.ID 103204]
2. Cita con resumen
Healy D. EMA acknowledges persistent sexual dysfunction after SSRIs & SNRIs. Rxisk 20019:11 de junio. [Ref.ID 103130]
6. Cita con resumen
Anónimo. Finasteride: rare reports of depression and suicidal thoughts. Drug Safety Update 2017;10:2-3. [Ref.ID 101600]
7.Enlace a cita original Cita con resumen
Lineberry N, Berlin JA, Mansi B, Glasser S, Berkwits M, Klem C, Bhattacharya A, Citrome L, Enck R, Fletcher J, Haller D, Chen T-T, Laine C. Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective. BMJ 2016;354:i5078. [Ref.ID 100797]
8. Cita con resumen
11.Tiene citas relacionadas Cita con resumen
Weitzman ER, Kelemen S, Quinn M, Eggleston EM, Mandl KD. Participatory surveillance of hypoglycemia and harms in an online social network. JAMA Intern Med 2013;173:345-51. [Ref.ID 95090]
12. Cita con resumen
Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD, for the CONSORT PRO Group. Reporting on patient-reported outcomes in randomized trials: The CONSORT PRO extension. JAMA 2013;309:814-22. [Ref.ID 94991]
13. Cita con resumen
14. Cita con resumen
White RW, Tatonetti NP, Shah NH, Horvitz E. Web-scale pharmacovigilance: listening to signals from the crowd. J Am Med Inform Assoc 2013;20:404-8. [Ref.ID 94824]
15. Cita con resumen
Kuehn BM. Drugs and liver injury. JAMA 2012;308:2073. [Ref.ID 94163]
16. Cita con resumen
Herxheimer A, Vohra S, Edwards R. Drug safety reporting. A major rethink is needed. N Engl J Med 2012;367:26. [Ref.ID 93807]
17.Enlace a cita original Cita con resumen
Anderson C, Krska J, Murphy E, Avery A, on behalf of the Yellow Card Study Collaboration. The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol 2011;72:806-22. [Ref.ID 91788]
18.Tiene citas relacionadas Cita con resumen
Jha AK, Classen DC. Getting moving on patient safety - Harnessing electronic data for safer care. N Engl J Med 2011;365:1756-8. [Ref.ID 91643]
19.Tiene citas relacionadas Cita con resumen
Classen DC, Resar R, Griffin F, Federico F, Frankel T, Kimmel N, Whittington JC, Frankel A, Seger A, James BC. 'Global trigger tool' shows that adverse events in hospitals may be ten times greater than previously measured. Health Affairs 2011;30:581-9. [Ref.ID 90387]
20. Cita con resumen
McLernon DJ, Bond CM, Hannaford PC, Watson MC, Lee AJ, Hazell L, Avery A, on behalf of the Yellow Card Collaboration. Adverse Drug Reaction reporting in the UK: a retrospective observational comparison of Yellow Card reports submitted by patients and healthcare professionals. Drug Saf 2010;33:775-88. [Ref.ID 89272]
Seleccionar todas
 1 a 20 de 20